Vaso Occlusive Crisis clinical trials

Explore recruiting vaso occlusive crisis clinical trials.

Recruiting vaso occlusive crisis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vaso Occlusive Crisis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Lidocaine for opioid sparing in vaso-occlusive crisis of Sickle Cell Disease

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety of Anumigilimab (CSL324) in Adults with Sickle Cell Disease

Belgium, Netherlands, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A 52-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, flexible-adaptive, Phase 3 study to evaluate the efficacy and safety of rilzabrutinib in participants aged 10 to 65 years with sickle-cell disease

Spain, France, Netherlands, Belgium, Greece, Germany +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric Emergency Department: a Double Blind Randomized versus placebo Controlled Trial (INVOPE)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 / Phase 3, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Adaptive Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents with Sickle Cell Disease during Vaso-Occlusive Crisis

Spain, Italy, Greece, Netherlands, Belgium, Germany +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

Evaluation of the efficacy of iloprost in the management of vaso-occlusive crises in adult patients with sickle cell: a multicentre, randomised, double-blind, placebo-controlled study _ PROSTASICKLE

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Vaso Occlusive Crisis trials by city

Vaso Occlusive Crisis in Toronto Vaso Occlusive Crisis in Vancouver Vaso Occlusive Crisis in Montreal Vaso Occlusive Crisis in Calgary Vaso Occlusive Crisis in Edmonton Vaso Occlusive Crisis in Ottawa Vaso Occlusive Crisis in Winnipeg Vaso Occlusive Crisis in Quebec City Vaso Occlusive Crisis in Hamilton Vaso Occlusive Crisis in Kitchener Vaso Occlusive Crisis in London Vaso Occlusive Crisis in Halifax Vaso Occlusive Crisis in New York Vaso Occlusive Crisis in Los Angeles Vaso Occlusive Crisis in Chicago Vaso Occlusive Crisis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease